{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:32Z","timestamp":1759401812567},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2007,10,24]],"date-time":"2007-10-24T00:00:00Z","timestamp":1193184000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0001063","type":"journal-article","created":{"date-parts":[[2007,10,23]],"date-time":"2007-10-23T21:06:25Z","timestamp":1193173585000},"page":"e1063","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Protection of Rhesus Monkeys by a DNA Prime\/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens"],"prefix":"10.1371","volume":"2","author":[{"given":"Walter R.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Bostick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Conteh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Fryauff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manmohan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffery B.","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2007,10,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14728214.10.3.489","article-title":"Malaria vaccines in development.","volume":"10","author":"WR Ballou","year":"2005","journal-title":"Expert Opin Emerg Drugs"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.2004.71.239","article-title":"Update on the clinical development of candidate malaria vaccines.","volume":"71","author":"WR Ballou","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1371\/journal.pctr.0010005","article-title":"RTS,S\/AS02A Malaria Vaccine Does Not Induce Parasite CSP T Cell Epitope Selection and Reduces Multiplicity of Infection.","volume":"1","author":"S Enosse","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0140-6736(04)17223-1","article-title":"Efficacy of the RTS,S\/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.","volume":"364","author":"PL Alonso","year":"2004","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(05)67669-6","article-title":"Duration of protection with RTS,S\/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.","volume":"366","author":"PL Alonso","year":"2005","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.vaccine.2005.01.142","article-title":"Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.","volume":"23","author":"DG Heppner Jr","year":"2005","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0264-410X(00)00036-0","article-title":"Safety and immunogenicity of a three-component blood-stage malaria vaccine in adults living in an endemic area of Papua New Guinea.","volume":"18","author":"B Genton","year":"2000","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/339342","article-title":"A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.","volume":"185","author":"B Genton","year":"2002","journal-title":"J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"6300","DOI":"10.1128\/IAI.72.11.6300-6305.2004","article-title":"Strain-specific humoral response to a polymorphic malaria vaccine.","volume":"72","author":"C Fluck","year":"2004","journal-title":"Infect Immun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.meegid.2006.03.006","article-title":"Effect of the malaria vaccine Combination B on merozoite surface antigen 2 diversity.","volume":"7","author":"C Fluck","year":"2007","journal-title":"Infect Genet Evol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jbiotec.2005.08.025","article-title":"Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.","volume":"121","author":"CW Tsai","year":"2006","journal-title":"J Biotechnol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1128\/IAI.01679-05","article-title":"Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.","volume":"74","author":"S Singh","year":"2006","journal-title":"Infect Immun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.012590199","article-title":"A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum.","volume":"99","author":"AW Stowers","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1128\/IAI.70.12.6961-6967.2002","article-title":"Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria.","volume":"70","author":"AW Stowers","year":"2002","journal-title":"Infect Immun"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1745-7270.2006.00178.x","article-title":"Immunogenicity of C-terminus of Plasmodium falciparum merozoite surface protein 1 expressed as a non-glycosylated polypeptide in yeast.","volume":"38","author":"ZG Zhang","year":"2006","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/IAI.73.7.3963-3970.2005","article-title":"posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.","volume":"73","author":"B Giersing","year":"2005","journal-title":"Infect Immun"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1242\/jeb.00646","article-title":"Progress in the development of recombinant and synthetic blood-stage malaria vaccines.","volume":"206","author":"S Mahanty","year":"2003","journal-title":"J Exp Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1016\/j.vaccine.2005.11.028","article-title":"Phase I safety and immunogenicity trial of FMP1\/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.","volume":"24","author":"CF Ockenhouse","year":"2006","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12736","DOI":"10.1073\/pnas.0501808102","article-title":"Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket.","volume":"102","author":"T Bai","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","article-title":"Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1.","author":"CR Collins","year":"2006","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1016\/j.vaccine.2004.09.040","article-title":"A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant.","volume":"23","author":"A Saul","year":"2005","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pep.2006.06.018","article-title":"Production and characterization of clinical grade Escherichia coli derived Plasmodium falciparum 42 kDa merozoite surface protein 1 (MSP1(42)) in the absence of an affinity tag.","volume":"50","author":"RL Shimp Jr","year":"2006","journal-title":"Protein Expr Purif"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1128\/IAI.70.7.3493-3499.2002","article-title":"Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.","volume":"70","author":"M Sedegah","year":"2002","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"5905","DOI":"10.4049\/jimmunol.164.11.5905","article-title":"Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.","volume":"164","author":"M Sedegah","year":"2000","journal-title":"J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1073\/pnas.95.13.7648","article-title":"Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine.","volume":"95","author":"M Sedegah","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/0264-410X(94)90078-7","article-title":"Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine.","volume":"12","author":"SL Hoffman","year":"1994","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes.","volume":"20","author":"SC Gilbert","year":"2002","journal-title":"Vaccine"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.4049\/jimmunol.172.5.3094","article-title":"Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus.","volume":"172","author":"RJ Anderson","year":"2004","journal-title":"J Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.0105-2896.2004.00138.x","article-title":"Progress in DNA-based heterologous prime-boost immunization strategies for malaria.","volume":"199","author":"AC Moore","year":"2004","journal-title":"Immunol Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8<sup>+<\/sup> T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara.","volume":"4","author":"J Schneider","year":"1998","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.vaccine.2005.10.058","article-title":"Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.","volume":"24","author":"DP Webster","year":"2006","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1128\/IAI.74.5.2706-2716.2006","article-title":"Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.","volume":"74","author":"M Walther","year":"2006","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1073\/pnas.0406381102","article-title":"Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara.","volume":"102","author":"DP Webster","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1128\/IAI.00590-06","article-title":"A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.","volume":"74","author":"SJ Dunachie","year":"2006","journal-title":"Infect Immun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nri1746","article-title":"Pre-erythrocytic malaria vaccines: towards greater efficacy.","volume":"6","author":"AV Hill","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1016\/j.vaccine.2006.06.022","article-title":"Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men.","volume":"24","author":"EB Imoukhuede","year":"2006","journal-title":"Vaccine"},{"key":"ref38","article-title":"Intramuscular administration of a malaria DNA vaccine is safe, well-tolerated and induces CTL, but not detectable antibodies, in healthy human volunteers.","author":"TP Le","year":"1999","journal-title":"Vaccine: In press"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/S0264-410X(99)00407-7","article-title":"Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.","volume":"18","author":"TP Le","year":"2000","journal-title":"Vaccine"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.vaccine.2004.01.031","article-title":"Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S\/AS02A.","volume":"22","author":"JE Epstein","year":"2004","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1089\/10430340260201644","article-title":"Safety, Tolerability, and Lack of Antibody Responses After Administration of a PfCSP DNA Malaria Vaccine via Needle or Needle-Free Jet Injection, and Comparison of Intramuscular and Combination Intramuscular\/Intradermal Routes.","volume":"13","author":"JE Epstein","year":"2002","journal-title":"Hum Gene Ther"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10817","DOI":"10.1073\/pnas.181123498","article-title":"Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.","volume":"98","author":"R Wang","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.4049\/jimmunol.172.9.5561","article-title":"Induction in Humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.","volume":"172","author":"R Wang","year":"2004","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1128\/IAI.73.5.2863-2872.2005","article-title":"Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.","volume":"73","author":"R Wang","year":"2005","journal-title":"Infect Immun"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/IAI.69.9.5565-5572.2001","article-title":"Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques.","volume":"69","author":"WO Rogers","year":"2001","journal-title":"Infect Immun"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/IAI.70.8.4329-4335.2002","article-title":"Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimen.","volume":"70","author":"WO Rogers","year":"2002","journal-title":"Infect Immun"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"8189","DOI":"10.1128\/JVI.79.13.8189-8200.2005","article-title":"Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins.","volume":"79","author":"GR Otten","year":"2005","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/IAI.73.2.828-833.2005","article-title":"CpG oligodeoxynucleotides adsorbed onto polylactide-co-glycolide microparticles improve the immunogenicity and protective activity of the licensed anthrax vaccine.","volume":"73","author":"H Xie","year":"2005","journal-title":"Infect Immun"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymeth.2006.05.017","article-title":"Microparticle-based technologies for vaccines.","volume":"40","author":"DT O'Hagan","year":"2006","journal-title":"Methods"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1128\/JVI.75.19.9037-9043.2001","article-title":"Induction of potent immune responses by cationic microparticles with adsorbed human immunodeficiency virus DNA vaccines.","volume":"75","author":"D O'Hagan","year":"2001","journal-title":"J Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-1759(00)00310-0","article-title":"ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques.","volume":"247","author":"A Kumar","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.1016\/j.vaccine.2006.02.041","article-title":"Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S\/AS02A.","volume":"24","author":"DS Walsh","year":"2006","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0020-7519(02)00181-9","article-title":"Exploring the proteome of Plasmodium.","volume":"32","author":"DJ Carucci","year":"2002","journal-title":"Int J Parasitol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01107","article-title":"A proteomic view of the Plasmodium falciparum life cycle.","volume":"419","author":"L Florens","year":"2002","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum.","volume":"419","author":"MJ Gardner","year":"2002","journal-title":"Nature"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molbiopara.2005.03.018","article-title":"Transcriptional Analysis of <italic>Plasmodium yoelii<\/italic> Liver Stage Gene Expression.","volume":"142","author":"JB Sacci Jr","year":"2005","journal-title":"Mol Biochem Parasitol"},{"key":"ref57","first-page":"417","article-title":"Functional proteome and expression analysis of sporozoites and hepatic stages of malaria development.","volume":"295","author":"PL Blair","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref58","article-title":"Laser capture microdissection and molecular analysis of Plasmodium yoelii liver-stage parasites.","author":"JB Sacci","year":"2000"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.M311331200","article-title":"A role for apical membrane antigen 1 during invasion of hepatocytes by Plasmodium falciparum sporozoites.","volume":"279","author":"O Silvie","year":"2004","journal-title":"J Biol Chem"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1086\/427243","article-title":"Calculation of liver-to-blood inocula, parasite growth rates, and preerythrocytic vaccine efficacy, from serial quantitative polymerase chain reaction studies of volunteers challenged with malaria sporozoites.","volume":"191","author":"P Bejon","year":"2005","journal-title":"J Infect Dis"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.gt.3302139","article-title":"Reduced immunogenicity of DNA vaccine plasmids in mixtures.","volume":"11","author":"M Sedegah","year":"2004","journal-title":"Gene Ther"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/sj.gene.6364125","article-title":"Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.","volume":"5","author":"M Sedegah","year":"2004","journal-title":"Genes Immun"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4161\/hv.3.2.3833","article-title":"Reduced production of RNA transcripts from individual DNA plasmids given in a multivalent DNA vaccine formula.","volume":"3","author":"DJ Bacon","year":"2007","journal-title":"Hum Vaccin"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4269\/ajtmh.2004.70.499","article-title":"Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.","volume":"70","author":"DS Walsh","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1128\/IAI.00774-06","article-title":"Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-naive and malaria-exposed individuals.","volume":"74","author":"P Bejon","year":"2006","journal-title":"Infect Immun"},{"key":"ref66","first-page":"1","article-title":"The dissection of CD8 T cells during liver-stage infection.","volume":"297","author":"U Krzych","year":"2005","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0001063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:48:25Z","timestamp":1589021305000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0001063"}},"subtitle":[],"editor":[{"given":"Derya","family":"Unutmaz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,10,24]]},"references-count":66,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2007,10,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0001063","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,10,24]]}}}